Triglyceride glucose related indices predict incident breast cancer risk in a population based cohort study. 2025

Qing Xie, and Yaolan Zhen, and Zhixing Fan, and Ying Hu
Department of Oncology, Xianning Central Hospital, The First Affiliated Hospital of Hubei Institute of Science and Technology, Xianning, 437100, Hubei, China.

BACKGROUND The association between triglyceride-glucose (TyG)-related indices and breast cancer risk is not fully understood. This study aimed to investigate the role of TyG-related indices in predicting breast cancer risk. METHODS We analyzed data from 220,396 female participants in the UK Biobank, with a median follow-up of 13.63 years. TyG-related indices including TyG, TyG-body mass index (TyG-BMI), TyG-waist circumference (TyG-WC), TyG-waist to height ratio (TyG-WHtR), TyG-waist to hip ratio (TyG-WHR). Cox proportional hazards models were used to evaluate the association between TyG-related indices and breast cancer risk. Mediation analysis was performed to assess the role of white blood cell (WBC) and C-reactive protein (CRP) in this association. Interaction analysis was conducted to assess if age, menopausal status, and breast cancer screening modified the association between TyG-related indices and breast cancer risk. RESULTS The highest quartiles of TyG, TyG-BMI, TyG-WC, TyG-WHtR, and TyG-WHR were significantly associated with increased breast cancer risk, with hazard ratios (95% CI) of 1.10 (1.04-1.17), 1.28 (1.20-1.35), 1.30 (1.22-1.38), 1.23 (1.16-1.31), and 1.17 (1.10-1.24), respectively. Interaction analysis revealed stronger associations in postmenopausal women, those aged ≥ 60, and individuals who had not undergone breast cancer screening (P for interaction < 0.05). Mediation analysis showed that CRP contributed a larger proportion of the mediation effect than WBC, with CRP mediating 26.8%-54.7% and WBC mediating 14.3%-40.4%. CONCLUSIONS TyG-related indices were significantly associated with increased breast cancer risk, highlighting their potential as biomarkers for risk assessment and prevention strategies.

UI MeSH Term Description Entries

Related Publications

Qing Xie, and Yaolan Zhen, and Zhixing Fan, and Ying Hu
April 2024, Zhonghua xin xue guan bing za zhi,
Qing Xie, and Yaolan Zhen, and Zhixing Fan, and Ying Hu
July 2020, BMC endocrine disorders,
Qing Xie, and Yaolan Zhen, and Zhixing Fan, and Ying Hu
January 2019, Canadian journal of gastroenterology & hepatology,
Qing Xie, and Yaolan Zhen, and Zhixing Fan, and Ying Hu
December 2020, Breast cancer research and treatment,
Qing Xie, and Yaolan Zhen, and Zhixing Fan, and Ying Hu
May 2016, Cancer causes & control : CCC,
Qing Xie, and Yaolan Zhen, and Zhixing Fan, and Ying Hu
June 2020, BMJ open gastroenterology,
Qing Xie, and Yaolan Zhen, and Zhixing Fan, and Ying Hu
February 2023, Cancer epidemiology,
Qing Xie, and Yaolan Zhen, and Zhixing Fan, and Ying Hu
November 2022, Diabetes & metabolism,
Copied contents to your clipboard!